Breast cancer. Relationship to thyroid supplements for hypothyroidism

Area of Science:

• Endocrinology
• Oncology
• Epidemiology

Background:

• Thyroid hormone plays a crucial role in cellular metabolism and growth.
• Previous research has suggested potential links between thyroid function and cancer risk.
• The specific relationship between exogenous thyroid supplementation and breast cancer requires further elucidation.

Purpose of the Study:

• To investigate the association between the use of thyroid supplements and the risk of developing breast cancer.
• To quantify the incidence of breast cancer in patients receiving thyroid supplements versus a control group.
• To explore potential dose-response or duration-dependent relationships.

Main Methods:

• Retrospective cohort study design.
• Inclusion of patients receiving thyroid supplements and a matched control group.
• Analysis of breast cancer incidence rates based on supplement usage, duration, and patient characteristics (e.g., nulliparity, age).

Main Results:

• The incidence of breast cancer was significantly higher in the thyroid supplement group (12.13%) compared to the control group (6.2%).
• Breast cancer incidence increased with the duration of thyroid supplement use, reaching 19.48% for over 15 years of use.
• Nulliparous women on thyroid supplements had a substantially higher incidence (33%) versus controls (9.25%).
• Elevated breast cancer rates were observed across specific age groups among thyroid supplement users.

Conclusions:

• Thyroid supplement use is associated with an increased risk of breast cancer.
• The duration of thyroid supplementation may correlate with a higher incidence of breast cancer.
• Specific populations, such as nulliparous women, may be at a greater risk when using thyroid supplements.